免疫学
CD19
癌症研究
干细胞
CD8型
临床试验
医学
生物
内科学
抗原
细胞生物学
作者
Marianna Sabatino,Jinhui Hu,Michele Sommariva,Sanjivan Gautam,Vicki Fellowes,James D. Hocker,Sean C. Dougherty,Haiying Qin,Christopher A. Klebanoff,Terry J. Fry,Ronald E. Gress,James N. Kochenderfer,David F. Stroncek,Yun Ji,Luca Gattinoni
出处
期刊:Blood
[American Society of Hematology]
日期:2016-07-28
卷期号:128 (4): 519-528
被引量:300
标识
DOI:10.1182/blood-2015-11-683847
摘要
Key Points A platform for the generation of clinical-grade CD19-CAR–modified TSCM. CD19-CAR–modified TSCM mediate superior antitumor responses compared with CD19-CAR T cells currently used in clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI